CBN Sleep Gummies: New Study Finds Tolerance and Withdrawal Signs in Mice After Five Days

Freddy Krueger made staying awake a survival strategy. The wellness industry has turned falling asleep into a product category. Somewhere between the melatonin spray and the magnesium powder on your bathroom shelf, there may now be a small jar of gummies with three letters on the label: CBN. They promise calm nights, often with the reassuring word herbal attached. A new study from the University of Connecticut suggests the story is more complicated, at least in mice.

What CBN actually is

Cannabinol, or CBN, is one of the lesser known compounds in the cannabis plant. It has an unusual origin. Unlike most cannabinoids, it does not come from its own precursor in the plant. It forms when THC, the main intoxicating compound in cannabis, breaks down through oxidation, for example when cannabis is exposed to heat, light or air for a long time. That is why aged cannabis contains more of it. Historically CBN even holds a small record: it was the first cannabinoid ever isolated from cannabis, back in 1896.

CBN is considered mildly psychoactive. It acts on the same cannabinoid receptors as THC, but binds more weakly. In recent years manufacturers have discovered it as a selling point. In the United States you can find it in gummies, tinctures and capsules, often marketed as a gentler alternative for sleep and relaxation. If you have scrolled through wellness content late at night, the irony of that will not be lost on you.

What the new study found

The research team around lead author Olivia Vanegas and Steven Kinsey of the Elisabeth DeLuca School of Nursing at UConn published its findings in the journal Drug and Alcohol Dependence. The paper appeared online in September and is part of the November issue. The university publicised it in late October, which is when the results reached a wider audience.

The researchers gave mice CBN twice a day for five days. Over that time the animals became less responsive to several typical cannabinoid effects, including reduced movement, pain relief and a drop in body temperature. In plain terms they developed tolerance. The mice also responded less to a synthetic cannabinoid, which points to cross-tolerance.

Then came the more striking part. When the researchers gave a drug that blocks the main cannabinoid receptor, the CBN-treated mice showed signs of withdrawal, such as head twitches and paw tremors. In a further experiment mice that had been trained to recognise the effects of THC treated CBN as if it were THC. The authors conclude that repeated CBN use can produce tolerance and physical dependence in mice.

There was a second, less discussed finding. According to the university’s summary, CBN reduced inflammation even at lower doses that had no psychoactive effects. During a simulated bacterial infection, however, it weakened the animals’ ability to defend themselves.

Why a mouse study does not answer your question

Before you clear out your nightstand, a reality check. This is an animal study. Mice are not small humans. The doses used in a laboratory cannot simply be compared with a gummy from the supermarket shelf. The press coverage does not state the exact amounts in a way that allows that comparison. The study also did not measure sleep. It says nothing about whether CBN helps you sleep or not.

The researchers themselves are careful. Kinsey said CBN may still have therapeutic value, but that until more is known about dosing and long-term effects, the message for consumers is buyer beware. Vanegas put the problem more bluntly: “The marketing of minor cannabinoids is pretty wild right now.”

That is the heart of the matter. The study does not prove that CBN is dangerous for people. It shows that a substance often sold as harmless and non-habit-forming behaves, in animals, more like its famous relative THC than the packaging suggests.

And does it help you sleep?

Here the evidence is thin. In a randomised placebo-controlled trial published in 2023, around 300 adults with poor sleep took 20 milligrams of CBN, alone or combined with CBD, for seven nights. Compared with placebo, CBN did not significantly improve overall sleep quality. It did reduce how often participants woke up during the night and lowered overall sleep disturbance. Adding CBD did not improve the effect. Another trial tested a manufacturer’s own proprietary CBN formulation. Large, independent long-term studies in humans are still missing.

So if you have the impression that a CBN gummy gives you a better night, that may be true for you. It may also be the ritual, the expectation or simply the fact that you went to bed earlier. Science cannot yet separate these effects cleanly.

The regulators are catching up

The study lands in the middle of a regulatory shift in the United States. A federal law signed in November 2025 redefines hemp products. Among other things it limits finished hemp products to 0.4 milligrams of total THC per container. Most of these rules were delayed and are now set to take effect on December 11, 2026. The law does not mention CBN by name. How regulators will treat it is still unclear, according to Nature World News. In Europe the rules differ from country to country, so what you can buy online is not always what you can legally buy at home.

For your own decisions that leaves a sober conclusion. Dietary supplements in the United States are not reviewed by the FDA for safety or effectiveness before they go on sale. The actual content of cannabinoid products can differ from the label. If you take sleep aids regularly, the more useful question may not be which gummy to buy but why sleep has become so difficult in the first place. That is a conversation worth having with a doctor rather than with an algorithm at two in the morning.

This article is for general information only and does not replace medical advice. If you have persistent sleep problems or are considering supplements, please speak to a doctor or pharmacist.